Ethyl 7-oxo-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-c]pyridine-3-carboxylate

Catalog No. :
ACELFX215
CAS No. :
1313532-55-6
Molecular Formula :
C9H11N3O3
Molecular Weight :
209.21

IUPAC Name:ethyl 7-oxo-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-c]pyridine-3-carboxylate

Ethyl 7-oxo-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-c]pyridine-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$96.00Login to see priceInquiryInquiry
100mg95%$163.00Login to see priceInquiryInquiry
250mg95%$275.00Login to see priceInquiryInquiry
1g95%$742.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 7-oxo-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-c]pyridine-3-carboxylate
IUPAC Nameethyl 7-oxo-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-c]pyridine-3-carboxylate
MDL No.MFCD24445388
Molecular FormulaC9H11N3O3
Molecular Weight209.21
SMILESO=C(OCC)C1=C(C2=NN1)CCNC2=O
InChI KeyVNDGHBFEIPEUBT-UHFFFAOYSA-N
Synonymethyl 7-oxo-2,4,5,6-tetrahydropyrazolo[3,4-c]pyridine-3-carboxylate;1H-Pyrazolo[3,4-c]pyridine-3-carboxylic acid, 4,5,6,7-tetrahydro-7-oxo-, ethyl ester
CAS No.1313532-55-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACELFX215 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACELFX215 route product structure diagram
    ACELFX2151313532-55-6
Inquiry

2. ACELFX215 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACELFX215 route product structure diagram
    ACELFX2151313532-55-6
Inquiry

Comments (0)